These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 11807614)
1. Functional genomics and proteomics--the role of nuclear medicine. Haberkorn U; Altmann A; Eisenhut M Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):115-32. PubMed ID: 11807614 [TBL] [Abstract][Full Text] [Related]
2. Radionuclide imaging in the post-genomic era. Haberkorn U; Altmann A J Cell Biochem Suppl; 2002; 39():1-10. PubMed ID: 12552596 [TBL] [Abstract][Full Text] [Related]
3. Impact of functional genomics and proteomics on radionuclide imaging. Haberkorn U; Altmann A; Mier W; Eisenhut M Semin Nucl Med; 2004 Jan; 34(1):4-22. PubMed ID: 14735455 [TBL] [Abstract][Full Text] [Related]
4. Functional genomics and radioisotope-based imaging procedures. Haberkorn U; Altmann A Ann Med; 2003; 35(6):370-9. PubMed ID: 14572160 [TBL] [Abstract][Full Text] [Related]
5. PET and SPECT. Haberkorn U Handb Exp Pharmacol; 2008; (185 Pt 2):13-35. PubMed ID: 18626597 [TBL] [Abstract][Full Text] [Related]
6. Modulation of tracer accumulation in malignant tumors: gene expression, gene transfer, and phage display. Haberkorn U Curr Top Dev Biol; 2005; 70():145-69. PubMed ID: 16338341 [TBL] [Abstract][Full Text] [Related]
7. Scintigraphic imaging of gene expression and gene transfer. Haberkorn U; Mier W; Eisenhut M Curr Med Chem; 2005; 12(7):779-94. PubMed ID: 15853711 [TBL] [Abstract][Full Text] [Related]
8. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Aardema MJ; MacGregor JT Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602 [TBL] [Abstract][Full Text] [Related]
10. Where are we in genomics? Hocquette JF J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195 [TBL] [Abstract][Full Text] [Related]
11. Functional genomics to new drug targets. Kramer R; Cohen D Nat Rev Drug Discov; 2004 Nov; 3(11):965-72. PubMed ID: 15520818 [TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. Taking a functional genomics approach in molecular medicine. Yaspo ML Trends Mol Med; 2001 Nov; 7(11):494-501. PubMed ID: 11689334 [TBL] [Abstract][Full Text] [Related]
15. Chemical genomics and medicinal systems biology: chemical control of genomic networks in human systems biology for innovative medicine. Kim TK J Biochem Mol Biol; 2004 Jan; 37(1):53-8. PubMed ID: 14761303 [TBL] [Abstract][Full Text] [Related]
16. Making the Case for Functional Proteomics. Perkins RC Methods Mol Biol; 2019; 1871():1-40. PubMed ID: 30276729 [TBL] [Abstract][Full Text] [Related]
17. Expression genomics and drug development: towards predictive pharmacology. Liu ET Brief Funct Genomic Proteomic; 2005 Feb; 3(4):303-21. PubMed ID: 15814022 [TBL] [Abstract][Full Text] [Related]